Altimmune, Inc. Banner Image

Altimmune, Inc.

  • Ticker ALT
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Altimmune, Inc. Logo Image
  • 51-200 Employees
  • Based in Gaithersburg, Maryland
Altimmune is a clinical stage biopharmaceutical company focused on developing intranasal vaccines, immune modulating therapies and treatments for liver disease. Their diverse pipeline includes proprietary intranasal vaccines for COVID-19 (AdCOVID™), anthrax (NasoShield™) and influenza (NasoVAX™); an intranasal immune modulating therapeutic for COVID-19 (T-COVID™); and next generation peptideMore therapeutics for NASH (ALT-801) and chronic hepatitis B (HepTcell™).
4.7 / 5.0 (172)

Altimmune, Inc. reports have an aggregate usefulness score of 4.7 based on 172 reviews.

Altimmune, Inc.

Most Recent Annual Report

Altimmune, Inc.
MOST RECENT 2023 Annual Report and Form 10K

Older/Archived Annual Reports

Altimmune, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!